50
Views
2
CrossRef citations to date
0
Altmetric
Original Research

The role of plasma N-terminal brain natriuretic pro-peptide in diagnosing elderly patients with acute exacerbation of COPD concurrent with left heart failure

, , , , , , , & show all
Pages 2931-2940 | Published online: 21 Sep 2018

References

  • RussellRNorcliffeJBafadhelMChronic obstructive pulmonary disease: management of chronic diseaseMedicine2016445310313
  • Global Initiative for Chronic Obstructive Lung Disease (GOLD) [webpage on the Internet]The Global Strategy for the Diagnosis, Management and Prevention of COPD, updated 2013 Available from: http://www.goldcopd.org/Accessed December 20, 2013
  • SapeyEStockleyRACOPD exacerbations. 2: aetiologyThorax200661325025816517585
  • KoFWChanKPHuiDSAcute exacerbation of COPDRespirology20162171152116527028990
  • ZengQJiangSUpdate in diagnosis and therapy of coexistent chronic obstructive pulmonary disease and chronic heart failureJ Thorac Dis20124331031522754671
  • BhattSPDransfieldMTChronic obstructive pulmonary disease and cardiovascular diseaseTransl Res2013162423725123727296
  • BafadhelMRussellREAre COPD and cardiovascular disease fundamentally intertwined?Eur Respir J20164751307130927132259
  • UkenaCMahfoudFKindermannMThe cardiopulmonary continuum systemic inflammation as ‘common soil’ of heart and lung diseaseInt J Cardiol2010145217217620570377
  • de Miguel DíezJChancafe MorganJJiménez GarcíaRde MigueMJChancafeMJJiménezGRThe association between COPD and heart failure risk: a reviewInt J Chron Obstruct Pulmon Dis2013830531223847414
  • TsaiSHLinYYChuSJHsuCWChengSMInterpretation and use of natriuretic peptides in non-congestive heart failure settingsYonsei Med J201051215116320191004
  • don-WauchopeACMckelvieRSEvidence based application of BNP/NT-proBNP testing in heart failureClin Biochem2015484–523624625448029
  • OremusMMckelvieRdon-WauchopeAA systematic review of BNP and NT-proBNP in the management of heart failure: overview and methodsHeart Fail Rev201419441341924953975
  • PavasiniRTavazziGBiscagliaSAmino terminal pro brain natriuretic peptide predicts all-cause mortality in patients with chronic obstructive pulmonary disease: Systematic review and meta-analysisChron Respir Dis201714211712627956645
  • RalucaHMariaAMagdaBNatriuretic peptides in heart failure coexisting with chronic obstructive pulmonary diseaseExp Clin Cardiol20142016061614
  • MillerMRHankinsonJBrusascoVStandardisation of spirometryEur Respir J200526231933816055882
  • KilcoyneMMDavisALFerrerMIA dynamic electrocardiographic concept useful in the diagnosis of corpulmonale. Result of a survey of 200 patients with chronic obstructive pulmonary diseaseCirculation19704259039244249377
  • LangRMBadanoLPMor-AviVRecommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular ImagingEur Heart J Cardiovasc Imaging201516323327125712077
  • de Oliveira CastroYTBRolimILTPSilvaACOSilvaLDCKnowledge and meaning of cardiac catheterization from the perspective of cardiac patientsRev Rene20161712935
  • FihnSDBlankenshipJCAlexanderKPACC/AHA/AATS/PCNA/SCAI/STS focused update of the guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines, and the American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic SurgeonsCirculation2014130191749176725070666
  • JamesPAOparilSCarterBLEvidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8)JAMA2014311550752024352797
  • GarberAJAbrahamsonMJBarzilayJIAACE/ACE comprehensive diabetes management algorithm 2015Endocr Pract201521443844725877012
  • MacdonaldMIShafuddinEKingPTChangCLBardinPGHancoxRJCardiac dysfunction during exacerbations of chronic obstructive pulmonary diseaseLancet Respir Med20164213814826781000
  • AndersonWJLipworthBJRekhrajSStruthersADGeorgeJLeft ventricular hypertrophy in COPD without hypoxemia: the elephant in the room?Chest20131431919722797769
  • ReichekNCorpulmonaleparvus: patting the elephantJ Am Coll Cardiol201464192010201225440096
  • KawutSMPoorHDParikhMACor Pulmonale Parvus in Chronic Obstructive Pulmonary Disease and EmphysemaJ Am Coll Cardiol201464192000200925440095
  • AbrougFOuanes-BesbesLDetection of acute heart failure in chronic obstructive pulmonary disease patients: role of B-type natriuretic peptideCurr Opin Crit Care200814334034718467897
  • ArjamaaONikinmaaMNatriuretic peptides in hormonal regulation of hypoxia responsesAm J Physiol Regul Integr Comp Physiol20092962R257R26419005014
  • JörgensenKMüllerMFNelJUptonRNHoultzERickstenSEReduced intrathoracic blood volume and left and right ventricular dimensions in patients with severe emphysema: an MRI studyChest200713141050105717426209
  • ShahKSMaiselASFonarowGCTroponin in Heart FailureHeart Fail Clin2018141576429153201
  • LalaRIPuschitaMDarabantiuDPilatLGalectin-3 in heart failure pathology – “another brick in the wall”?Acta Cardiol201570332333126226706
  • MccarthyCPJanuzziJLSoluble ST2 in Heart FailureHeart Fail Clin2018141414829153199
  • BatlleMRecarte-PelzPRoigEAXL receptor tyrosine kinase is increased in patients with heart failureInt J Cardiol2014173340240924681018
  • SrivatsanVGeorgeMShanmugamEUtility of galectin-3 as a prognostic biomarker in heart failure: where do we stand?Eur J Prev Cardiol20152291096111025268020
  • Bayes-GenisAde AntonioMVilaJHead-to-head comparison of 2 myocardial fibrosis biomarkers for long-term heart failure risk stratification: ST2 versus galectin-3J Am Coll Cardiol201463215816624076531